Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Recognized from beginning deferred revenue by Quarter
Recognized from beginning deferred revenue — Other revenue ($M) ($M)
Moderna Recognized from beginning deferred revenue: $64M in Q2 2026, up 28.0% from a year earlier.
Where the Q2 2026 figure comes from
Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)
Source: Form 10-Q (filed 2026-07-31) ↗
Reported in Form 10-Q / 10-K Note 2 (Contract Liabilities).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Recognized from beginning deferred revenue — Other revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 64 | +28.0% | Form 10-Q (filed 2026-07-31) ↗ |
| Q1 2026 | Mar 31, 2026 | 53 | +278.6% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 2 | – | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 146 | – | Form 10-Q (filed 2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 50 | – | Form 10-Q (filed 2025-08-01) ↗ |
| Q1 2025 | Mar 31, 2025 | 14 | – | Form 10-Q (filed 2025-05-01) ↗ |
Cite this data
StockData. (2026). Moderna Recognized from beginning deferred revenue ($M), quarterly Q1 2025–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/def-rev-rec-other
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.